Verition Fund Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196K | Sell |
|
|||||
|
2025
Q1 | $524K | Buy |
|
|||||
|
2024
Q4 | $409K | Buy |
|
|||||
|
2024
Q3 | $300K | Sell |
|
|||||
|
2024
Q2 | $880K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $189K | Sell |
|
|||||
|
2023
Q3 | $347K | Buy |
|
|||||
|
2023
Q2 | $216K | Buy |
|
|||||
|
2023
Q1 | $186K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $252K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $231K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1.86M | Buy |
|